Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19 pandemic, substance use disorders and body image issues, a worrisome correlation.

European review for medical and pharmacological sciences·2022
Same author

Postnatal nutritional treatment of neurocognitive deficits in fetal alcohol spectrum disorder.

Biochemistry and cell biology = Biochimie et biologie cellulaire·2017
Same author

[Prenatal maltreatment].

Anales de pediatria (Barcelona, Spain : 2003)·2015
Same author

Arsenic levels in immigrant children from countries at risk of consuming arsenic polluted water compared to children from Barcelona.

Environmental monitoring and assessment·2015
Same author

Prenatal ethanol exposure and placental hCG and IGF2 expression.

Placenta·2015
Same author

Viral coinfection in childhood respiratory tract infections.

Archivos de bronconeumologia·2014
Same journal

[Annual report of Anales de Pediatría editors].

Anales de pediatria (Barcelona, Spain : 2003)·2024
Same journal

[COVID-19: Critical appraisal of the evidence].

Anales de pediatria (Barcelona, Spain : 2003)·2024
Same journal

[Usefulness of chest ultrasound in a neonatal infection due to SARS-CoV-2].

Anales de pediatria (Barcelona, Spain : 2003)·2024
Same journal

[Cutaneous manifestations in the current pandemic of coronavirus infection disease (COVID 2019)].

Anales de pediatria (Barcelona, Spain : 2003)·2024
Same journal

[Breastfeeding app updates and recommendations].

Anales de pediatria (Barcelona, Spain : 2003)·2024
Same journal

[The impact of the pandemic on vaccination coverage in Spain: a challenge for pediatrics and public health].

Anales de pediatria (Barcelona, Spain : 2003)·2024
See all related articles

Related Experiment Video

Updated: Jul 6, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

[Is parapneumonic empyema increasing?]

O García-Algar, A Martínez-Roig

    Anales De Pediatria (Barcelona, Spain : 2003)
    |March 18, 2008
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: Jul 6, 2026

    Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
    11:32

    Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

    Published on: February 23, 2014